COWEN FINANCIAL PRODUCTS LLC

Company

Coeptis Therapeutics Holdings, Inc.

Filed

November 4, 2020

Accession Number

0001085146-20-002744

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →